Huston Thad Allen (CIK 1706052) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-10). Recent activity: Buy ARTV (220,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Financial Officer | Buy | 220,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-10